The ERCC6 gene and age-related macular degeneration
- PMID: 21072178
- PMCID: PMC2967476
- DOI: 10.1371/journal.pone.0013786
The ERCC6 gene and age-related macular degeneration
Abstract
Background: Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in the developed countries and is caused by both environmental and genetic factors. A recent study (Tuo et al., PNAS) reported an association between AMD and a single nucleotide polymorphism (SNP) (rs3793784) in the ERCC6 (NM_000124) gene. The risk allele also increased ERCC6 expression. ERCC6 is involved in DNA repair and mutations in ERCC6 cause Cockayne syndrome (CS). Amongst others, photosensitivity and pigmentary retinopathy are hallmarks of CS.
Methodology/principal findings: Separate and combined data from three large AMD case-control studies and a prospective population-based study (The Rotterdam Study) were used to analyse the genetic association between ERCC6 and AMD (2682 AMD cases and 3152 controls). We also measured ERCC6 mRNA levels in retinal pigment epithelium (RPE) cells of healthy and early AMD affected human donor eyes. Rs3793784 conferred a small increase in risk for late AMD in the Dutch population (The Rotterdam and AMRO-NL study), but this was not replicated in two non-European studies (AREDS, Columbia University). In addition, the AMRO-NL study revealed no significant association for 9 other variants spanning ERCC6. Finally, we determined that ERCC6 expression in the human RPE did not depend on rs3793784 genotype, but, interestingly, on AMD status: Early AMD-affected donor eyes had a 50% lower ERCC6 expression than healthy donor eyes (P = 0.018).
Conclusions/significance: Our meta-analysis of four Caucasian cohorts does not replicate the reported association between SNPs in ERCC6 and AMD. Nevertheless, our findings on ERCC6 expression in the RPE suggest that ERCC6 may be functionally involved in AMD. Combining our data with those of the literature, we hypothesize that the AMD-related reduced transcriptional activity of ERCC6 may be caused by diverse, small and heterogeneous genetic and/or environmental determinants.
Conflict of interest statement
Figures


Similar articles
-
Haplotypes of HTRA1 rs1120638, TIMP3 rs9621532, VEGFA rs833068, CFI rs10033900, ERCC6 rs3793784, and KCTD10 rs56209061 Gene Polymorphisms in Age-Related Macular Degeneration.Dis Markers. 2019 Sep 8;2019:9602949. doi: 10.1155/2019/9602949. eCollection 2019. Dis Markers. 2019. PMID: 31583032 Free PMC article.
-
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition.Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9256-61. doi: 10.1073/pnas.0603485103. Epub 2006 Jun 5. Proc Natl Acad Sci U S A. 2006. PMID: 16754848 Free PMC article.
-
A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.Hum Mutat. 2008 Jan;29(1):113-22. doi: 10.1002/humu.20610. Hum Mutat. 2008. PMID: 17854076 Free PMC article.
-
Novel frame shift mutation in ERCC6 leads to a severe form of Cockayne syndrome with postnatal growth failure and early death: A case report and brief literature review.Medicine (Baltimore). 2018 Aug;97(33):e11636. doi: 10.1097/MD.0000000000011636. Medicine (Baltimore). 2018. PMID: 30113454 Free PMC article. Review.
-
Associations Between the T280M and V249I SNPs in CX3CR1 and the Risk of Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5590-8. doi: 10.1167/iovs.15-16830. Invest Ophthalmol Vis Sci. 2015. PMID: 26305531 Review.
Cited by
-
The Rotterdam Study: 2012 objectives and design update.Eur J Epidemiol. 2011 Aug;26(8):657-86. doi: 10.1007/s10654-011-9610-5. Epub 2011 Aug 30. Eur J Epidemiol. 2011. PMID: 21877163 Free PMC article.
-
DNA Damage and Repair in Eye Diseases.Int J Mol Sci. 2023 Feb 15;24(4):3916. doi: 10.3390/ijms24043916. Int J Mol Sci. 2023. PMID: 36835325 Free PMC article. Review.
-
A novel heterozygous ERCC6 variant identified in a Chinese family with non-syndromic primary ovarian insufficiency.Mol Genet Genomic Med. 2022 Oct;10(10):e2040. doi: 10.1002/mgg3.2040. Epub 2022 Aug 16. Mol Genet Genomic Med. 2022. PMID: 35975393 Free PMC article.
-
Secondary analysis of publicly available data reveals superoxide and oxygen radical pathways are enriched for associations between type 2 diabetes and low-frequency variants.Ann Hum Genet. 2013 Nov;77(6):472-81. doi: 10.1111/ahg.12035. Epub 2013 Aug 14. Ann Hum Genet. 2013. PMID: 23941231 Free PMC article.
-
Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.Gastroenterology. 2015 Dec;149(7):1872-1883.e9. doi: 10.1053/j.gastro.2015.08.052. Epub 2015 Sep 5. Gastroenterology. 2015. PMID: 26344056 Free PMC article.
References
-
- Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572. - PubMed
-
- Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205–210. - PubMed
-
- Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1646–1651. - PubMed
-
- Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123:321–327. - PubMed
-
- Edwards AO, Ritter R, III, Abel KJ, Manning A, Panhuysen C, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–424. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical